Top Medical Searches

FDA Approves Siliq (brodalumab) for Plaque Psoriasis

February 15, 2017 — The U.S. Food and Drug Administration today approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection.
Siliq is intended for patients who are candidates for… Read More..

Be Sociable, Share!
February 14th, 2017 Posted in NewDrugs
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us